TY - JOUR
AU - Jørgensen, Svend
AB -  treatment of intermittent claudication - a double-blind, placebo controlled study. Intern Med 1 9 9 2 : 231: 261-7. Sloth-Nielsen J, Culdager B. Mouritzen C. Lund EB. Egeblad M, Norregaard 0. Jorgensen SJ, Jelnes R. Arteriographic findings in EDTA chelation therapy on peripheral arteriosclerosis. Arn 1 Surg 1 9 9 1 : 1 6 2 : 122-5. van Rij AM, Solomon C. Packer SGK. Hopkins WG. Chelation therapy for intermittent claudication : a double-blind, randomized, controlled trial. Circulation 1 9 9 4 : 90: 1194-9. Olszewer E. Carter JP. EDTA chelation therapy in chronic degenerative disease. Med Hyp 1 9 8 8 : 2 7 : 41-9. Chappell LT. Stahl JP. The correlation between EDTA chelation therapy and improvement in cardiovascular function: a metaanalysis. 1 Adv Med 1 9 9 3 : 6: 139-60. Chappell LT. Stahl JP.Evans R. EDTA chelation treatment for vascular disease: a meta-analysis using unpublished data. 1 Adv Med 1 9 9 4 : 7: 1 3 1 4 2 . Hancke C. Flytlie K. Benefits of EDTA chelation therapy on arteriosclerosis. 1 Adv Med 1 9 9 3 : 6 : 161-72. Editorial EDTA chelation: a rebutal. 1 Adv Med 1 9 9 
TI - Reply
JO - Journal of Internal Medicine
DO - 10.1111/j.1365-2796.1995.tb01198.x
DA - 1995-04-01
UR - https://www.deepdyve.com/lp/wiley/reply-GeHItnmIC0
SP - 430
VL - 237
IS - 4
DP - DeepDyve
ER -